Maxim Group Reiterates Hold Rating for Cellectar Biosciences (NASDAQ:CLRB)
Cellectar Biosciences (NASDAQ:CLRB – Get Free Report)‘s stock had its “hold” rating reiterated by analysts at Maxim Group in a report issued on Wednesday, MarketBeat.com reports. Separately, StockNews.com initiated coverage on shares of Cellectar Biosciences in a research note on Tuesday. They set a “sell” rating for the company. View Our Latest Stock Analysis on […]
Cellectar Biosciences (NASDAQ:CLRB – Get Free Report)‘s stock had its “hold” rating reiterated by analysts at Maxim Group in a report issued on Wednesday, MarketBeat.com reports. Separately, StockNews.com initiated coverage on shares of Cellectar Biosciences in a research note on Tuesday. They set a “sell” rating for the company. View Our Latest Stock Analysis on […]
